Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine

International Journal of Obesity

Volumn 29, Issue 2, 2005, Pages 208-216

  Hainer, V ^a   Kunesova, M ^a   Bellisle, F ^b   Hill, M ^a   Braunerova, R ^a   Wagenknecht, M ^a   Hlubik, Pavol ^c   Hruby, Ivo ^c   Svacina, Stepan ^c   Stich, Vladimir ^c  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b HÔTEL DIEU   (France)

^c NONE

Author keywords

Body mass index; Depression; Dietary restraint; Disinhibition; Macronutrient intake; Sibutramine; Weight loss predictors

Indexed keywords

PLACEBO; SIBUTRAMINE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR; BEHAVIOR THERAPY; BODY MASS; CALORIC INTAKE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUNGER; MAJOR CLINICAL STUDY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; APPETITE DEPRESSANTS; BODY MASS INDEX; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOBUTANES; DEPRESSION; DIET, REDUCING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MIDDLE AGED; NUTRITION PHYSIOLOGY; OBESITY; PATIENT COMPLIANCE; PROGNOSIS; REGRESSION ANALYSIS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 19944431663     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802850     Document Type: Article

References (40)

1. Flatt J-P, Tremblay A. Substrate balances and weight maintenance. In: Bray GA, Bouchard C, James WPT (eds) Handbook of obesity. Marcel Dekker: New York; 1998. pp 528-532.
2. Beck AT, Ward CH, Mendeson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiat 1961; 4: 561-571.
3. Clark MM, Niaura R, King TK, Pera V. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav 1996; 21: 509-513.
4. Delahanty LM, Meigs JB, Hayden D, Williamson DA, Nathan DM. Psychological and behavioral correlates of baseline BMI in the Diabetes Prevention Program (DPP). Diabetes Care 2002; 25: 1992-1998.
5. Hainer V, Kunesova M, Parizkova J, Stich V. Depression score and Eating Inventory in obese women followed for two years after initial one-month VLCD treatment [Abstract]. Int J Obes Relat Metab Disord 1997; 21 (suppl 2): S113.
6. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29: 71-83.
7. Foster GD, Wadden TA, Swain RM, Stunkard AJ, Platte P, Vogt RA. The Eating Inventory in obese women: clinical correlates and relationship to weight loss. Int J Obes Relat Metab Disord 1998; 22: 778-785.
8. Adami GF, Gandolfo P, Meneghelli A, Gianetta E, Camerini G, Scopinaro N. Preoperative eating behavior and weight-loss following gastric banding for obesity. Obes Surg 1996; 6: 244-246.
9. Westerterp-Plantenga MS, Kempen KP, Saris WHM. Determinants of weight maintenance in women after diet-induced weight reduction. Int J Obes Relat Metab Disord 1998; 22: 1-6.
10. Lejeune MP, van Aggel-Leijssen DP, van Baak MA, Westerterp-Plantenga MS. Effects of dietary restraint vs. exercise during weight maintenance in obese men. Eur J Clin Nutr 2003; 57: 1338-1344.
11. Westenhoefer J, von Falck B, Stellfeldt A, Fintelmann S. Behavioural correlates of successful weight reduction over 3 y Results from the Lean Habits Study. Int J Obes Relat Metab Disord 2004; 28: 334-335.
12. Womble LG, Williamson DA, Greenway FL, Redmann SM. Psychological and behavioral predictors of weight loss during drug treatment for obesity. Int J Obes Relat Metab Disord 2001; 25: 340-345.
13. Kelly F, Wade AG, Jones SP, Johnson SG. Sibutramine hydrochloride vs. dexfenfluramine: weight loss in obese subjects [abstract]. Int J Obes Relat Metab Disord 1994; 18 (Suppl 2): 61.
14. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Rel Metab Disord 1999; 23: 1016-1024.
15. James WPT, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WHM, Van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000; 356: 2119-2125.
16. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity. JAMA 2003; 289: 1805-1812.
17. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB. Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189-198.
18. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet 1989; 11: 1142-1145.
19. Hansen DL, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rossner S, Saris WHM, Van Gaal LF, James WPT, Goulder M, for the STORM study group. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Int J Obes Rel Metab Disord 2001; 25: 496-501.
20. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Kopperschaar HP, Krempf M. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentric Orlistat Study Group. Lancet 1998; 352: 167-172.
21. Karhunen L, Franssila-Kallunki A, Rissanen P, Valve R, Kolehmainen M, Rissanen A, Uusitupa M. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. Int J Obes Relat Metab Disord 2000; 24: 1567-1572.
22. Grilo CM. On the relationship of attempting to lose weight, restraint, and binge eating in outpatients with binge eating disorder. Obes Res 2000; 8: 638-645.
23. McGuire MT, Jeffrey RW, French SA, Hannan PJ. The relationship between restraint and weight and weight-related behaviors among individuals in a community weight gain prevention trial. Int J Obes Relat Metab Disord 2001; 25: 574-580.
24. Bjorvell H, Rossner S, Stunkard AJ. Obesity, weight loss and dietary restraint. Int J Eat Disord 1986; 5: 727-734.
25. Laporte DJ, Stunkard AJ. Predicting attrition and adherence to a very low calorie diet: a prospective investigation of the Eating Inventory. Int J Obes Relat Metab Disord 1990; 14: 197-206.
26. Baucom DH, Aiken PA. Effect of depressed mood on eating among nonobese dieting and nondieting persons. J Personal Soc Psychol 1981; 41: 577-585.
27. Wadden TA, Stunkard AJ, Brownell KD, Day SC. Treatment of obesity by behaviour therapy and very low calorie diet: a pilot investigation. J Consult Clin Psychol 1984; 52: 692-694.
28. Wadden TA, Stunkard AJ, Day SC, Gould RA, Rubin CJ. Less food, less hunger: reports of appetite and symptoms in a controlled study of a protein-sparing modified fast. Int J Obes Relat Metab Disord 1987; 11: 239-249.
29. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998; 6: 1-11.
30. Prewitt TE, Schmeisser D, Bowen PE, Aye P, Dolecek TA, Langenberg P, Cole T, Brace L. Changes in body weight, body composition, and energy intake in women fed high- and low-fat diets. Am J Clin Nutr 1991; 54: 304-310.
31. Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO. The role of low-fat diets in body weight control: meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 2000; 24: 1545-1552.
32. Barkeling B, Rossner S, Bjorvell H. Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. Int J Obes Relat Metab Disord 1990; 14: 743-751.
33. Crovetti R, Porrini M, Santangelo A, Testolin G. The influence of thermic effect of food on satiety. Eur J Clin Nutr 1998; 52: 482-488.
34. Kabrnova K, Braunerova R, Aldhoon B, Hlavaty P, Wagenknecht M, Kunesova M, Parizkova J, Hainer V. Association of changes in macronutrient and calcium intakes with body weight changes in obese subjects. Int J Obes Relat Metab Disord 2004; 28 (suppl 1): S138.
35. Westerterp-Plantenga MS, Lejeune MP, Nijs I, van Ooijen M, Kovacs EM. High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord 2004; 28: 57-64.
36. Ben-Menachem E, Axelsen M, Johanson EH, Stagge A, Smith U. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003; 11: 556-562.
37. Lejeune MP, Hukshorn CJ, Saris WH, Westerterp-Plantenga MS. Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men. Int J Obes Relat Metab Disord 2003; 27: 1494-1499.
38. Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab 2000; 2: 105-112.
39. Scholze J. Sibutramine in clinical practice - a PMS-study with positive effects on blood pressure and metabolic parameters. Dtsch Med Wochenschr 2002; 127: 606-610.
40. Hauner H, Meier M, Jockel KH, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825 T polymorphism. Pharmacogenetics 2003; 13: 453-459.